Mahesh Krishnan insider trades

Open-market stock purchases and sales by Mahesh Krishnan, Director at Halozyme Therapeutics, Inc, from SEC Form 4 filings since Apr 2, 2022.

Recent trades

DateStockTradeValue
Jun 29, 2026HALO Halozyme Therapeutics, IncSold$548K
Jun 29, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
May 5, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
May 5, 2026HALO Halozyme Therapeutics, IncBought (not open market)—

Companies traded

  • HALO Halozyme Therapeutics, Inc: 1 sale, last Jun 29, 2026
  • KDNY Chinook Therapeutics, Inc: 1 sale, last Aug 11, 2023

Get free alerts when Mahesh Krishnan files a new trade →